Nuclear medicine slump hits Sopha
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the last three quarters.
The nuclear medicine market nosedived in the fourth quarterof 1993, and by most accounts has yet to return to its formerstrength (SCAN 4/6/94). Gamma camera vendors have been scramblingto adapt, including Sopha competitor ADAC Laboratories, whichimplemented a similar downsizing earlier this year (SCAN 5/4/94).
Most of the lost jobs at Sopha will come from production andadministrative support personnel, the Columbia, MD-based companysaid. Sopha has taken pains to avoid impacting customer serviceor R&D, according to president Colin McNaught.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
